Subscription form

GaBI Online offers the easiest way to keep busy healthcare professionals up to date with the developments and latest news in generic and biosimilar medicines. The GaBI Online Newsletter includes noteworthy news, ongoing generics and biosimilars research, guidelines, policies and legislations under scrutiny, and synopses of past and future pharma events.

Sign up today to receive your FREE weekly updates on generic and biosimilar medicines development!

Bioequivalence

Formulas and processes

Generics and biosimilar manufacturing

Improved formulations and routes of administration

Interview reports with industry stakeholders

Immunogenicity, naming, interchangeability and substitution

Legal and regulatory issues

Licensing, pricing and reimbursement policies

Marketing of generics and biosimilars

National and international guidelines for manufacturing, quality assessment and licensing

New generics/biosimilar introductions

News of pharmaceutical industry

Patent issues

Prescriber and patient education

Quality, safety and efficacy

Scientific aspects of generics and protein drugs development

Supply chain management

Third party payers policies

WHO pre-qualification programmes

*required field


Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048